|1.||Devor, M: 5 articles (05/2008 - 10/2001)|
|2.||Sukhotinsky, I: 4 articles (05/2008 - 12/2006)|
|3.||Devor, Marshall: 3 articles (01/2016 - 09/2005)|
|4.||Kronenberg, Jona: 3 articles (09/2011 - 02/2005)|
|5.||Reiner, K: 3 articles (05/2008 - 12/2006)|
|6.||Dou, Shuping: 2 articles (05/2008 - 02/2008)|
|7.||Liu, Guozheng: 2 articles (05/2008 - 02/2008)|
|8.||Hnatowich, Donald J: 2 articles (05/2008 - 02/2008)|
|9.||Rusckowski, Mary: 2 articles (05/2008 - 02/2008)|
|10.||Hopkins, D A: 2 articles (03/2007 - 12/2006)|
02/01/2008 - "The maximum percent tumor accumulation (MPTA) of the labeled cMORF was subsequently determined by a dosage study of labeled cMORF. "
02/01/2008 - "However, the MPTA in this tumor model is lower than that in the LS174T tumor model investigated earlier, possibly due to a lower tumor blood supply."
02/01/2008 - "The MPTA of the labeled cMORF in the CWR22 tumor was 2.22%ID/g compared to only 0.12%ID/g in control mice without pretargeting. "
05/01/2008 - "In conclusion, the MPTA cannot be improved through the use of different pretargeting antibodies, although different antibodies may improve the maximum absolute tumor accumulation, the heterogeneity, and/or the tumor-to-normal tissue ratios of the effector. "
05/01/2008 - "By comparing the pretargeting results of these three antibodies with our prediction, we confirmed that the MPTA of the radiolabeled cMORF effector in the LS174T tumor is independent of the antibodies. "
05/25/2007 - "Tracer studies have shown that the MPTA projects to the rostromedial medulla, an important reticulospinal relay for pain modulation and motor control. "
12/01/2006 - "Using neuroanatomical tracing methods we show that the MPTA has multiple descending projections to brainstem and spinal areas associated with pain modulation. "
05/01/2005 - "Pre-operatively and three months post-operatively the patients were physically examined (Insall score, step test, anterior knee pain, subjective feeling of instability and patient satisfaction) and limb alignment was measured by radiographs (mechanical axis, tibial slope, lateral distal femur angle [LDFA], medial proximal tibia angle [MPTA]). "
10/01/2001 - "The very existence of the MPTA locus has implications for an understanding of the neural circuits that control motor functions and pain sensation, and for the cerebral representation of consciousness."
09/05/2005 - "Microinjection of pentobarbital and GABA(A)-receptor agonists into a brainstem region we have called the mesopontine tegmental anesthesia area (MPTA; Devor and Zalkind  Pain 94:101-112) induces a general anesthesia-like state. "
|3.||Congenital Abnormalities (Deformity)
09/01/2012 - "The postoperative MPTA can be used to predict the change in correction angle and an MPTA of at least 95° is the crucial angle with which to prevent recurrent varus deformity."
09/01/2012 - "By using the ROC curve, a one month MPTA of 95° was analyzed as the cut off point for preventing the recurrent varus deformity. "
08/01/2009 - "The MAC system was able to correct the deformity of Blount's disease as measured by a decrease in the MAD (40.2 +/- 29.3 mm; P </= 0.001) and TFA (15.9 +/- 13.7 degrees ; P </= 0.001), as well as an increase in the MPTA (15.7 +/- 14.6 degrees ; P = 0.001) at the time of fixator removal. "
04/01/2009 - "The lateral distal femoral angle (LDFA), the medial proximal tibial angle (MPTA), and the mechanical axis deviation (MAD) are commonly used in the evaluation of lower extremity deformities. "
09/01/2012 - "The hypothesis of our study is that post-osteotomy MPTA can predict the change in correction angle, and we aimed to determine the optimal MPTA with which to prevent recurrent varus deformity after MOWHTO. "
|4.||Unconsciousness (Loss of Consciousness)
01/01/2016 - "Combined with the prior microinjection data, we conclude that drug delivery to the MPTA is sufficient to induce loss-of-consciousness and that neurons in this locus are necessary for anesthetic induction at clinically relevant doses. "
03/01/2007 - "Using neuroanatomical tracing we identified four pathways ascending from the MPTA that are positioned to mediate electroencephalographic synchronization and loss of consciousness: (i) projections to the intralaminar thalamic nuclei that, in turn, project to the cortex; (ii) projections to several pontomesencephalic, diencephalic and basal forebrain nuclei that project cortically and are considered parts of an ascending "arousal system"; (iii) a projection to other parts of the subcortical forebrain, including the septal area, hypothalamus, zona incerta and striato-pallidal system, that may indirectly affect cortical arousal and hippocampal theta rhythm; and (iv) modest projections directly to the frontal cortex. "
05/27/2009 - "Microinjection of pentobarbital into a restricted region of rat brainstem, the mesopontine tegmental anesthesia area (MPTA), induces a reversible anesthesia-like state characterized by loss of the righting reflex, atonia, antinociception, and loss of consciousness as assessed by electroencephalogram synchronization. "
05/25/2007 - "However, we found that microinjection of GABAA-receptor (GABAA-R) active anesthetics into a restricted locus in the rat brainstem, the mesopontine tegmental anesthesia area (MPTA), rapidly induces a reversible anesthesia-like state characterized by suppressed locomotion, atonia, anti-nociception and loss of consciousness. "
05/20/2008 - "Microinjection of pentobarbital or other gamma-aminobutyric acid type A receptor (GABA(A)-R) active anesthetics into a brainstem region in the rat that we have called the mesopontine tegmental anesthesia area (MPTA) induces a general anesthesia-like state that includes suppression of locomotor activity, loss of the righting reflex, atonia, antinociception, and apparent loss of consciousness. "
|3.||Anesthetics (Anesthetic Agents)
|4.||gamma-Aminobutyric Acid (GABA)
|5.||GABA-A Receptor Agonists
|6.||GABA-A Receptors (GABA(A) Receptor)